NCT02988739View on ClinicalTrials.gov

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

September 30, 2017

Conditions
Influenza in Human
Interventions
BIOLOGICAL

seasonal influenza vaccine

influenza vaccine containing 15 µg haemagglutinin of three seasonal influenza virus strains recommended by WHO

DEVICE

fractional Er:Yag laser

Fraction laser device to apply micorpores of defined depth and density into skin.

Trial Locations (1)

1090

Medical University Vienna, University Clinic for Clinical Pharmacology, Vienna

Sponsors
All Listed Sponsors
collaborator

Medical University of Vienna

OTHER

lead

Pantec Biosolutions AG

INDUSTRY

NCT02988739 - Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine | Biotech Hunter | Biotech Hunter